Omada Health Target Price

See Omada Health's analyst price targets ($24) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.84

Average Target Price

$23.57

18.8% upside

7 analysts in the last 4 months

High: $30 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-21	Canaccord Genuity	$28	41.1% upside
2026-07-17	BTIG	$30	51.2% upside
2026-06-22	Morgan StanleyCraig Hettenbach	$30	51.2% upside
2026-05-08	Evercore ISI	$20	0.8% upside
2026-05-08	Wells Fargo	$18	9.3% downside
2026-05-08	Canaccord Genuity	$24	21% upside
2026-04-08	Evercore ISIElizabeth Anderson	$15	24.4% downside
2026-01-16	Goldman SachsDavid Roman	$26	31% upside
2026-01-09	Goldman Sachs	$29	46.2% upside
2026-01-08	Wells Fargo	$17	14.3% downside
2026-01-05	BarclaysSaket Kalia	$22	10.9% upside
2025-12-18	Morgan Stanley	$32	61.3% upside
2025-10-08	Evercore ISIElizabeth Anderson	$27	36.1% upside
2025-09-05	Robert W. Baird	$24	21% upside
2025-07-01	Needham	$23	15.9% upside

Omada Health (OMDA) FAQ

Omada Health posts a target price of $24. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $24 for OMDA means covering analysts, on average, see the stock 18.8% upside of $19.84 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for OMDA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Omada Health's other metric pages and overview cover the third.